Skip to content

Role of high dose radiotherapy in sugically incurable primary liver cancer.

Role of high dose conformal radiotherapy in unresectable hepatocellular carcinoma.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/05/003662
Enrollment
10
Registered
2013-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Hepatocellular Carcinoma.

Interventions

Intervention1: Three dimensional conformal radiotherapy.: Three dimensional conformal radiotherapy to the liver lesion for which the dose will be based on NTCP model for liver and Dose Volume histogr

Sponsors

Regional Cancer Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients who are not suitable for standard curative treatments of hepatocellular carcinoma. 2) Histological/cytological diagnosis of hepatocellular carcinoma or a patient with radiologically hyper-vascular liver tumour and a serum alpha-fetoprotein level >400ng/ml without evidence of any other alpha-fetoprotein secreting tumor. 3) Single tumour of size less than or equal to 10cms or two tumours of size less than or equal to 5cms. 4) Child Pugh Class A & B. 5) No evidence of distant metastasis. 6)Informed consent

Exclusion criteria

Exclusion criteria: 1) Pregnancy. 2) Patient who had prior radiotherapy to the treatment area. 3) Other concomitant severe systemic diseases 4)ECOG performance status of 2 or worser.

Design outcomes

Primary

MeasureTime frame
1)Assessment of objective response of hepatocellular carcinoma to high dose conformal external beam radiotherapy. 2)Evaluation of hepatic toxicity to radiotherapy at 6 weeks after radiation Timepoint: 6 weeks after completion of radiotherapy.

Secondary

MeasureTime frame
Median SurvivalTimepoint: 3 months after radiotherapy

Countries

India

Contacts

Public ContactDr C D Sivanandan

Regional Cancer Centre,Trivandrum.

jacob27john27@gmail.com9746046890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026